Use of a Self-Delivering Anti-CCL3 FANA Oligonucleotide as an Innovative Approach to Target Inflammation after Spinal Cord Injury
Nicolas Pelisch(Medical College of Wisconsin), Antje Kroner(Medical College of Wisconsin)
Cited by 21
Related Papers
mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis
|PLoS ONE|2008|73